SPYRAL GEMINI Pilot Study

NARecruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 22, 2029

Study Completion Date

December 22, 2029

Conditions
HypertensionVascular DiseasesCardiovascular DiseasesChronic Kidney DiseasesDiabetes Mellitus
Interventions
DEVICE

Multi-Organ Denervation Gemini System

After angiography according to standard procedures, subjects are treated with renal denervation followed by hepatic denervation.

Trial Locations (8)

6000

RECRUITING

Royal Perth Hospital (Dobney Hypertension Centre), Perth

11527

RECRUITING

Hippokration General Hospital, Athens

75226

RECRUITING

Baylor Heart & Vascular Hospital, Dallas

89502

RECRUITING

Renown Regional Medical Center, Reno

30309-1281

RECRUITING

Piedmont Heart Institute, Atlanta

48075-4818

RECRUITING

Henry Ford Providence Hospital, Southfield

38801-4934

RECRUITING

North Mississippi Medical Center, Tupelo

08103

RECRUITING

Virtua Our Lady of Lourdes Hospital, Camden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT06907147 - SPYRAL GEMINI Pilot Study | Biotech Hunter | Biotech Hunter